Bristol-Myers Squibb to Take Part in Leerink Swann Global Healthcare Conference
Get Alerts BMY Hot Sheet
Join SI Premium – FREE
NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Leerink Swann Global Healthcare Conference on Wednesday, February 10, 2016, in New York. Charles Bancroft, executive vice president and chief financial officer, will answer questions about the company at 1:25 p.m. EST.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160203005075/en/
Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
[email protected]
or
Investors:
Ranya
Dajani, 609-252-5330
[email protected]
Bill
Szablewski, 609-252-5894
[email protected]
Source: Bristol-Myers Squibb Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMS presents five-year Camzyos data for heart condition at ESC
- FirstEnergy Foundation Expands Fight Against Hunger With $5 Million Investment Across Six-State Region
- Action Behavior Centers' Family Advocacy Team Meets with Congressional Leaders in Washington, D.C., to Discuss Access to ABA Therapy for Autism
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share